GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
发明人:
HARLING, JOHN DAVID,TINWORTH, CHRISTOPHER
申请号：
CA3033001
公开号：
CA3033001A1
申请日:
2017.08.16
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
A kind of method of the kinase activity of relevant obstacle exception, wherein the kinases is. The relevant protein kinase 1 of adapter( AAK1 ),Aurora kinase( AURKA ),Aurora kinase B( AURKB ),Brutons tyrosine kinase( BTK ),Interleukin 1 receptor associated kinase 3( IRAK3 ),2 beta of protein-tyrosine( PTK2B ),The technology of tyrosine protein kinase( TEC ),Serine/threonine protein kitase Wee1( WEE1 ),Cyclin G-associated kinases( GAK ),Large area tumor inhibitor kinases( LATS1 ),Focal adhesion kinase( PTK2 ),Ribosomal protein L S6 kinase alpha-1( RPS6KA1 )The method includes the kinases of degrading.
